Dr Koh Liang Piu is an Associate Professor at the Department of Medicine, National University of Singapore Yong Loo Lin School of Medicine. He is also a senior consultant at the Department of Haematology-Oncology in the National University Cancer Institute, Singapore (NCIS).
His research interest is predominantly focused on the use of alternative donor transplant such as haploidentical and umbilical cord blood transplantation. He is the leading investigator on the use ex-vivo T-cell depleted haploidentical transplant for adult patients with haematological malignancies and bone marrow failure syndromes.
A/Prof Koh is the clinical director of the NCIS Adult Haematopoeitic Cell Transplant (HCT) programme at NCIS. Under his leadership, the NCIS Adult HCT programme has expanded and strengthened over the last 15 years, with notable developments such as expansion of the umbilical cord blood and haploidentical transplant programme, bringing the transplant outcome to levels comparable with the European and North American transplant centres. To date, he has performed more than 500 transplant for various haematological diseases.
A/Prof Koh is also the principal investigator of several international, multi-centre phase II/III clinical trials in the treatment of haematological malignancies, transplant-related infectious complications, studies on the use of umbilical cord transplant, alternative donor transplant, graft-versus-host disease (GVHD) treatment and prophylaxis, and novel approach in transplant conditioning regimens. He has published more than 70 peer reviewed papers and 3 book chapters on the topic of HCT, and has also presented more than 30 abstracts in international haematology/HCT meetings. He also serves as a reviewer for some of international peer reviewed transplantation or haematology journals such as Blood, Blood Advances, Transplantation, Leukemia and Lymphoma.
